Physician profile
Michael J Conrad
NPI 1790760452
$1,379.19
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $338 · 2020: $72.16 · 2021: $360 · 2022: $488 · 2023: $95.82 · 2024: $25.55.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $121.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $121.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $302.00 | 2021-2024 | Aptima, Coolseal Generator |
| Abbvie INC. | $244.37 | 2019-2022 | |
| Stryker Corporation | $144.87 | 2019 | |
| Channel Medsystems, INC. | $111.71 | 2022 | |
| Aspira Women'S Health INC | $110.19 | 2021 | |
| Pfizer INC. | $101.39 | 2019-2022 | |
| Myovant Sciences INC. | $58.87 | 2021-2022 | |
| Boston Scientific Corporation | $51.37 | 2023 | Solyx Sis System |
| Amag Pharmaceuticals, INC. | $46.92 | 2019 | |
| Lupin INC. | $43.27 | 2020-2021 | |
| Exeltis, USA INC. | $42.97 | 2019-2021 | |
| Minerva Surgical, INC | $26.89 | 2019 | |
| Becton, Dickinson and Company | $17.93 | 2022 | |
| Smith+Nephew, INC. | $17.90 | 2021 | |
| Astellas Pharma US INC | $16.79 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $15.91 | 2021 | |
| Therapeuticsmd, INC. | $14.40 | 2019 | |
| Avion Pharmaceuticals | $11.44 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Conrad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.